ClinicalTrials.govpublic full text
Phenelzine Sulfate and Docetaxel in Treating Patients With Prostate Cancer With Progressive Disease After First-Line Therapy With Docetaxel
hormone-resistant prostate cancer, metastatic prostatic adenocarcinoma, prostate adenocarcinoma, recurrent prostate carcinoma, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 884095
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.